Page 42 - Eric Domingo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEW DELHI (AP) — India’s prime minister received his second dose of the COVID-19 vaccine as the country hit another peak Thursday with 126,789 new cases reported in the past 24 hours. “Vaccination is among the few ways we have to defeat the virus. If you are eligible for the vaccine, get your shot soon,” Prime Minister Narendra Modi tweeted. He received his first vaccine shot on March 1. India started its vaccination drive in January. So far, more than 90 million health workers and Indians older than 45 have received at least one shot. Only 11 million of them have received...

Published April 9, 2021, 9:00 PM Conducting a clinical trial on the use of Ivermectin as a treatment for coronavirus disease (COVID-19) will not be needed in the Philippines due to several ongoing trials on its use around the world, Department of Science and Technology (DOST) Secretary Fortunato dela Peña said on Friday, April 9. Department of Science and Technology Secretary Fortunato dela Peña (TOTO LOZANO/ Presidential Photo / MANILA BULLETIN FILE PHOTO) “Clinical trial projects will require a minimum of six months and can extend to years. That is how long we have to wait to have resu...

Published April 9, 2021, 4:25 PM Food and Drug Administration (FDA) Director General Eric Domingo said the product label for the AstraZeneca vaccine will be updated to include information about the “very rare” possibility of blood clots among people who will be immunized against the coronavirus disease (COVID-19). (Photo by Fred TANNEAU / AFP / FILE PHOTO) In a media forum on Friday, April 9, Domingo said the FDA had a meeting with AstraZeneca on April 7 informing them about the product label update that will mention a “very rare side effect or very rare adverse event of blood clotting...

By JULIA MARI ORNEDO, GMA News Published April 9, 2021 6:48pm The Food and Drug Administration (FDA) on Friday said it approved the use of China’s Sinovac COVID-19 vaccine on the elderly because it was “more beneficial” to the vulnerable age group than having to wait for another brand to be available in the country. FDA chief Eric Domingo admitted that while data on CoronaVac’s efficacy among the elderly is “very limited,” there are no concerns on its safety based on the monitoring of some 700 senior citizen health workers who got the Chinese-made vaccine. “No’ng tining...

(JANSEN ROMERO / FILE PHOTO / MANILA BULLETIN) “Hindi naman namin bibigyan ng CSP [compassionate special permit] kung hindi eligible [yung hospital]. (We will not issue a CSP if the hospital is not eligible,” Domingo said in a Department of Health briefing on Friday, April 9. “Kaya po sya nabigyan ng CSP dahil nag apply po yung isang ospital at nasubmit naman niya lahat ng requirements na kinakailangan. (That’s why it was given a CSP because the hospital applied and it submitted all the requirements),” he added. Domingo explained that a doctor or hospital can request for a compassio...